Nexilico, Inc.

Nexilico, Inc.Nexilico, Inc.Nexilico, Inc.

Nexilico, Inc.

Nexilico, Inc.Nexilico, Inc.Nexilico, Inc.
  • Home
  • About Us
  • News
  • Contact Us
  • More
    • Home
    • About Us
    • News
    • Contact Us
  • Home
  • About Us
  • News
  • Contact Us

News

Wyatt Hartman joins Nexilico as the Director of R&D

Nexilico Awarded NIH Funding to Predict Gut Microbiome Effect on Drug Efficacy and Toxicity

Nexilico Awarded NIH Funding to Predict Gut Microbiome Effect on Drug Efficacy and Toxicity

Wyatt is an established computational biologist with more than 15 years of experience in development of a variety of microbiome technologies in multiple academic and industrial positions.

Learn more

Nexilico Awarded NIH Funding to Predict Gut Microbiome Effect on Drug Efficacy and Toxicity

Nexilico Awarded NIH Funding to Predict Gut Microbiome Effect on Drug Efficacy and Toxicity

Nexilico Awarded NIH Funding to Predict Gut Microbiome Effect on Drug Efficacy and Toxicity

  Nexilico and collaborators are awarded a grant to develop a new computational solution for reliable and cost-effective prediction of gut microbiome-mediated drug metabolism and its effect on drug efficacy and toxicity.  

Learn more

Nexilico and Microvi Biotech Inc. Awarded $1.12M by the National Institutes of Health

Nexilico Awarded NIH Funding to Predict Gut Microbiome Effect on Drug Efficacy and Toxicity

Nexilico Selected as one of the 30 NIH SBIR awardees to attend the BIO International Convention

Nexilico's collaboration with Microvi Biotech Inc. on developing precision biological processes receives a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant for $1.12M.

Learn more

Nexilico Selected as one of the 30 NIH SBIR awardees to attend the BIO International Convention

Nexilico Selected as one of the 30 NIH SBIR awardees to attend the BIO International Convention

Nexilico Selected as one of the 30 NIH SBIR awardees to attend the BIO International Convention

Nexilico, Inc. is selected by the National Institutes of Health, as one of the NIH SBIR awardees to exhibit  their technology at the upcoming Biotechnology Innovation Organization (BIO) International Convention.

Learn more

Nexilico Awarded Competitive Grant from the National Science Foundation

Nexilico Selected as one of the 30 NIH SBIR awardees to attend the BIO International Convention

The National Institutes of Health Awards Nexilico with Phase I SBIR Grant

Nexilico, Inc. has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $225,000 to conduct R&D work on the personalization of gut microbiome therapeutics.

Learn more

The National Institutes of Health Awards Nexilico with Phase I SBIR Grant

Nexilico Selected as one of the 30 NIH SBIR awardees to attend the BIO International Convention

The National Institutes of Health Awards Nexilico with Phase I SBIR Grant

Nexilico was selected to receive a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant for $225,000 to develop a predictive  platform for gut microbiome precision medicine. 

Learn more

Copyright © 2022 Nexilico, Inc. - All Rights Reserved.


This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept